Page last updated: 2024-12-09

5-carboxytetramethylrhodamine succinimidyl ester

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID2762600
MeSH IDM0295397

Synonyms (39)

Synonym
5-carboxy-tetramethylrhodamine n-succinimidyl ester, bioreagent, suitable for fluorescence
2-[3-(dimethylamino)-6-dimethylazaniumylidenexanthen-9-yl]-5-(2,5-dioxopyrrolidin-1-yl)oxycarbonylbenzoate
5-carboxytetramethylrhodamine succinimidyl ester
150810-68-7
5-carboxy-tetramethylrhodamine n-succinimidyl ester
4-carboxytetramethylrhodamine n-succinimidyl ester
AM84468
FT-0620196
T2808
CS-3860
2-[6-(dimethylamino)-3-(dimethyliminio)-3h-xanthen-9-yl]-5-{[(2,5-dioxopyrrolidin-1-yl)oxy]carbonyl}benzoate
DTXSID10376329
6-carboxytetramethylrhodaminen-hydroxysuccinimideester
c29h25n3o7
J-100077
5-carboxytetramethylrhodamine n-succinimidyl ester
5-tamra n-succinimidyl ester
2-(3,6-bis(dimethylamino)xanthylium-9-yl)-5-(((2,5-dioxopyrrolidin-1-yl)oxy)carbonyl)benzoate
HY-D0048
5-tamra-se
AKOS030528635
5-tamra se
mfcd07366710
xanthylium, 9-[2-carboxy-4-[[(2,5-dioxo-1-pyrrolidinyl)oxy]carbonyl]phenyl]-3,6-bis(dimethylamino)-, inner salt
AKOS027470183
5-carboxytetramethylrhodamine, succinimidyl ester
AS-47634
2-(3,6-bis(dimethylamino)xanthylium-9-yl)-5-((2,5-dioxopyrrolidin-1-yloxy)carbonyl)benzoate
2-[6-(dimethylamino)-3-(dimethyliminio)-3h-xanthen-9-yl]-5-[[(2,5-dioxopyrrolidin-1-yl)oxy]carbonyl]benzoate
5-carboxytetramethylrhodamine succinimidyl ester5-tamra-nhs ester
5-tamra-nhs ester
BP-25603
A897946
2-(3,6-bis(dimethylamino)xanthylium-9-yl)-5-(((2,5-dioxopyrrolidin-1-yl)oxy)carbonyl)benzoate;5-tamra-se
2-(6-(dimethylamino)-3-(dimethyliminio)-3h-xanthen-9-yl)-5-(((2,5-dioxopyrrolidin-1-yl)oxy)carbonyl)benzoate
B0001-331300
F14729
tamra nhs ester, 5-isomer
PD080082
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (179)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (2.79)18.2507
2000's51 (28.49)29.6817
2010's111 (62.01)24.3611
2020's12 (6.70)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 9.99

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index9.99 (24.57)
Research Supply Index5.23 (2.92)
Research Growth Index5.22 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (9.99)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (0.54%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other184 (99.46%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]